Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Sorror, Mohamed	Fred Hutchinson Cancer Center United States	Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality	5R01CA227092-06	Marjorie Perloff, M.D.
Spector, Tim	King'S College London United States	PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	1OT2CA297289-01	Asad Umar, D.V.M., Ph.D.
Spiegel, Brennan	Cedars-Sinai Medical Center United States	Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	5R01CA252211-05	Rachel Altshuler, Ph.D.
Stachler, Matthew D	University Of California, San Francisco United States	Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus	3R37CA269649-03S1	Matthew Young, Ph.D.
Staff, Nathan P	Mayo Clinic Rochester United States	Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity	5R01CA275870-03	Rachel Altshuler, Ph.D.
Stolley, Melinda R	Medical College Of Wisconsin United States	Every Day Counts: A lifestyle program for women metastatic breast cancer	5R01CA258759-04	Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Storz, Peter	Mayo Clinic Jacksonville United States	Deiminated molecules as markers for developing pancreatic cancer - A1	5R21CA279916-02	Matthew Young, Ph.D.
Suga, Jennifer Marie	Kaiser Foundation Research Institute United States	Kaiser Permanente NCI National Community Oncology Research Program, NCORP	3UG1CA189821-11S1	Vanessa A. White, M.P.H.
Sukumar, Saraswati	Johns Hopkins University United States	Development of an automated, point of care DNA methylation cartridge blood test for colorectal cancer detection in LMICs- an academic-industrial partnership	3R01CA278816-03S1	Matthew Young, Ph.D.
Sun, Ju	University Of Minnesota United States	SCH: A New Computational Framework for Learning from Imbalanced Biomedical Data	4R01CA287413-03	Claire Zhu, Ph.D.
Suter, Melissa J	Massachusetts General Hospital United States	Early Detection and Diagnosis of Lung Cancer with Endomicroscopy	5R01CA255326-04	Guillermo Marquez, Ph.D.
Svatek, Robert Scott	University Of Texas Hlth Science Center United States	eRapa for bladder cancer prevention	5R01CA252057-05	Howard L. Parnes, M.D.
Tabung, Fred Kinyuy	Ohio State University United States	Role of the inflammatory dietary pattern in gut and colon tissue microbiomes and impact on survival outcomes among colorectal cancer patients	1R21CA294050-01	Amit Kumar, Ph.D.
Tamkus, Deimante	Cook County Health And Hospital System United States	Stroger Hospital of Cook County (SHCC) MU-NCORP	3UG1CA190000-12S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Tanasova, Marina	Michigan Technological University United States	Molecular probes for targeting facilitative fructose transporters (GLUTs) in biochemical and biomedical applications	2R15CA242401-02A1	Wendy Wang, Ph.D., M.Sc.